Compare VIMTA LABS with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VIMTA LABS vs FOCUS BUSINESS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VIMTA LABS FOCUS BUSINESS VIMTA LABS/
FOCUS BUSINESS
 
P/E (TTM) x 25.0 - - View Chart
P/BV x 4.3 1.2 348.6% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 VIMTA LABS   FOCUS BUSINESS
EQUITY SHARE DATA
    VIMTA LABS
Mar-21
FOCUS BUSINESS
Mar-21
VIMTA LABS/
FOCUS BUSINESS
5-Yr Chart
Click to enlarge
High Rs193NA-   
Low Rs59NA-   
Sales per share (Unadj.) Rs95.371.9 132.5%  
Earnings per share (Unadj.) Rs9.70.7 1,429.6%  
Cash flow per share (Unadj.) Rs20.13.3 610.1%  
Dividends per share (Unadj.) Rs2.000-  
Avg Dividend yield %1.6NM- 
Book value per share (Unadj.) Rs87.914.2 617.4%  
Shares outstanding (eoy) m22.111.58 1,399.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.30-   
Avg P/E ratio x13.00-  
P/CF ratio (eoy) x6.30-  
Price / Book Value ratio x1.40-  
Dividend payout %20.70-   
Avg Mkt Cap Rs m2,7880-   
No. of employees `000NANA-   
Total wages/salary Rs m57825 2,271.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m2,107114 1,853.6%  
Other income Rs m80 1,727.1%   
Total revenues Rs m2,115114 1,853.1%   
Gross profit Rs m5305 10,184.0%  
Depreciation Rs m2314 5,574.4%   
Interest Rs m220 24,088.9%   
Profit before tax Rs m2851 19,682.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m710 18,776.3%   
Profit after tax Rs m2141 20,004.7%  
Gross profit margin %25.14.6 549.5%  
Effective tax rate %25.026.0 96.1%   
Net profit margin %10.20.9 1,074.9%  
BALANCE SHEET DATA
Current assets Rs m1,10530 3,625.3%   
Current liabilities Rs m53916 3,269.3%   
Net working cap to sales %26.912.3 218.2%  
Current ratio x2.11.8 110.9%  
Inventory Days Days183 590.1%  
Debtors Days Days12710,118,560 0.0%  
Net fixed assets Rs m1,6298 20,006.8%   
Share capital Rs m4416 279.9%   
"Free" reserves Rs m1,9007 28,352.2%   
Net worth Rs m1,94423 8,639.2%   
Long term debt Rs m1420 31,635.6%   
Total assets Rs m2,73439 7,035.3%  
Interest coverage x14.217.1 82.8%   
Debt to equity ratio x0.10 366.2%  
Sales to assets ratio x0.82.9 26.3%   
Return on assets %8.63.0 287.5%  
Return on equity %11.04.8 230.6%  
Return on capital %14.76.7 219.0%  
Exports to sales %26.90-   
Imports to sales %11.50-   
Exports (fob) Rs m566NA-   
Imports (cif) Rs m243NA-   
Fx inflow Rs m5660-   
Fx outflow Rs m2430-   
Net fx Rs m3230-   
CASH FLOW
From Operations Rs m3729 4,090.4%  
From Investments Rs m-319-3 9,976.3%  
From Financial Activity Rs m-46-1 3,906.0%  
Net Cashflow Rs m75 145.8%  

Share Holding

Indian Promoters % 37.5 71.1 52.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 1.4 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 62.5 28.9 216.5%  
Shareholders   19,947 74 26,955.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VIMTA LABS With:   HEALTHCARE GLOBAL ENTER.  FILTRA CONSULTANTS  W.H.BRADY  JAKHARIA FABRIC  EVANS ELECTRIC  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

VIMTA LABS 2020-21 Annual Report Analysis (Annual Result Update)

Nov 2, 2021 | Updated on Nov 2, 2021

Here's an analysis of the annual report of VIMTA LABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of VIMTA LABS. Also includes updates on the valuation of VIMTA LABS.

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

VIMTA LABS SHARE PRICE


Nov 26, 2021 (Close)

TRACK VIMTA LABS

  • Track your investment in VIMTA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE VIMTA LABS WITH

MARKET STATS